Up And Down The Ladder… Job Changes

6 Comments

ladder-3321Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

ed-garmeyAnd here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Cerulean Pharma hired Edward Garmey as chief medical officer. Previously, he was vp for clinical development at ArQule, where he developed and oversaw overseas clinical trials of its lead product types. Before ArQule, Garmey was medical director at GPC Biotech, where he was involved in overseeing global clinical development studies in oncology.

European Medicines Agency elected Kent Woods as its new chair;
Ampio Pharmaceuticals added David Stevens to its board;
Syndax added Arlene Morris to its board;
Kendle named Robert Shepard as exec director, oncology, medical affairs;
Kendle hired Pierre Geoffroy as vp, early stage programs;
Actelion promoted Otto Schwarz to chief operating officer;
Recombinant Data named David Hardison as managing director of health sciences;
Neoprobe hired Thomas Tulip as exec vp and chief business officer;
Asmacure hired Martin Driscoll as ceo;
DDN named Larry Sweeney as chief operating officer;
Xoma hired Paul Rubin as vp and chief medical officer;
Xoma named Patrick Scannon to exec vp and chief scientific officer;
Novella Clinical hired John Davidson as business development manager;
AbelsonTaylor promoted Kyler Queen, Jamie Wellinger and Ali Briceland to account executive;
Citi hired Andrew Baum as managing director, head of pharma and healthcare research for Europe;

Ladder shot thx to Robert CB on Flickr Creative Commons

Jump to comments

Share

Comments

  1. The title says up and DOWN the ladder. We need to see announcements for who got the boot and how far down the ladder they got kicked when the climb back on a lower rung.

  2. Abel, the best advice I ever got, which I’ve passed along to all my direct reports is: “Be nice to everyone you meet while you’re climbing the ladder; inevitably you will see some of them again when you’rew on your way back down”.

  3. Dear Abel,

    Thanks for your note. And I would be happy to include such information, so long as I am able (no pun intended) to not only obtain info about such job changes, but also verify them.

    So if you or anyone else is in a position to pass along job movement believed to be significant within whichever company or entity, please do so.

    Regards
    ed

  4. Ed, I can see the legitimate interest in announcing promotions and hires: its nice to recognize people’s accomplishments, and there is a legitimate public interest in knowing who is making decisions going forward.

    In most cases I don’t think similar value attaches to the posting of demotions and dismissals. In all but a handful of cases, its less newsworthy. Its disproportionately unkind to the person involved, and serves mainly to pander to those who enjoy reading about the misfortunes and personal failure of others (as is implied in the language of the request above).

  5. Hi Walter,

    I understand your point and don’t disagree entirely. However, there can be legitimate value and interest in the comings and goings involving folks at higher levels, given the sway they held over key units of an organization, or an entire organization.

    For that reason, I have always remained open to posting such movements, which I have actually done in the past.

    I hope this helps,
    ed

  6. I think the reader needs to infer the “demotions” by seeing the positions announced and having knowledge of that person’s prior position.

    Agree with Ed that only the most prominent firings (typically for legal transgressions) need to be tracked here. Not every blood lust needs to be satisfied.

Leave a Comment


- 1 = four

Subscribe

RSS Feed

Comments feed for this post only.

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/